nach oben

Canadian Journal of Anesthesia/Journal canadien d'anesthésie

Erschienen in:

03.04.2019 | Reports of Original Investigations

Intravenous dexmedetomidine for the treatment of shivering during Cesarean delivery under neuraxial anesthesia: a randomized-controlled trial

verfasst von: Christina Lamontagne, MD, FRCP, Sandra Lesage, MD, FRCP, Edith Villeneuve, MD, FRCP, Elsa Lidzborski, MD, Alex Derstenfeld, BASc, BCL, LLB, Chantal Crochetière, MD, FRCP

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

About 55% of patients undergoing a Cesarean delivery under spinal or epidural anesthesia will experience shivering, which may interfere with the monitoring of vital signs. Recent studies have shown that dexmedetomidine could potentially help to alleviate shivering associated with anesthesia. We investigated whether dexmedetomidine, an alpha 2-adrenergic agonist, reduces the duration of shivering associated with neuraxial anesthesia during Cesarean delivery.

Methods

Eighty parturients undergoing Cesarean delivery under neuraxial anesthesia and experiencing shivering were enlisted in this prospective, randomized, double-blind trial. After childbirth, the intervention group (n = 40) received a single intravenous bolus of dexmedetomidine (30 µg) while the control group (n = 40) received saline. Randomization and allocation were based on a computer-generated list. The primary outcome measure was the time required for an observable decrease in shivering after the intervention.

Results

One hundred fifty-five patients were recruited, 80 of whom presented with shivering and were randomized. Our study showed that dexmedetomidine reduced the mean (standard deviation) duration of shivering after a single intravenous bolus to 2.6 (2.1) min after dexmedetomidine from 17.9 (12.6) min after saline (difference in means, -15.3 min; 95% confidence interval [CI], -11.2 to -19.4). The effect of dexmedetomidine persisted 15 min after the bolus was administered, as shivering had completely stopped in 90% of the patients in the intervention group vs 22.5% in the control group (relative risk, 4.0; 95% CI, 2.2 to 7.2). No adverse effects, including bradycardia, were observed.

Conclusion

A single intravenous bolus of dexmedetomidine decreased the duration of shivering for up to 15 min during Cesarean delivery under neuraxial anesthesia.

Trial registration

www.clinicaltrials.gov (NCT02384343); registered 10 March, 2015.

Crowley LJ, Buggy DJ. Shivering and neuraxial anesthesia. Reg Anesth Pain Med 2008; 33: 241-52.CrossRefPubMed

De Witte J, Sessler DI. Perioperative shivering: physiology and pharmacology. Anaesthesia 2002; 96: 467-84.CrossRef

Tsai YC, Chu KS. A comparison of tramadol, amitriptyline, and meperidine for postepidural anesthetic shivering in parturients. Anesth Analg 2001; 93: 1288-92.CrossRefPubMed

Koczmara C, Perri D, Hyland S, Rousseaux L. Meperidine (demerol) safety issues. Dynamics 2005; 16: 8-12.PubMed

O’Connor AB, Lang VJ, Quill TE. Eliminating analgesic meperidine use with a supported formulary restriction. Am J Med 2005; 118: 885-9.CrossRefPubMed

Nair AS, Sriprakash K. Dexmedetomidine in pregnancy: Review of literature and possible use. J Obstet Anesth Crit Care 2013; 3: 3-6.CrossRef

Bicer C, Esmaoglu A, Akin A, Boyaci A. Dexmedetomidine and meperidine prevent postanaesthetic shivering. Eur J Anaesthesiol 2006; 23: 149-53.CrossRefPubMed

Ozaki M, Takeda J, Tanaka K, et al. Safety and efficacy of dexmedetomidine for long-term sedation in critically ill patients. J Anesth 2013; 28: 38-50.CrossRefPubMedPubMedCentral

Whalen LD, Di Gennaro JL, Irby GA, Yanay O, Zimmerman JJ. Long-term dexmedetomidine use and safety profile among critically ill children and neonates. Pediatr Crit Care Med 2014; 15: 706-14.CrossRefPubMed

10.

Chrysostomou C, Schulman SR, Castellanos H, et al. A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr 2014; 164: 276-82.e1-3.

11.

El-Tahan MR, Mowafi HA, Al Sheikh IH, Khidr AM, Al-Juhaiman RA. Efficacy of dexmedetomidine in suppressing cardiovascular and hormonal responses to general anaesthesia for caesarean delivery: a dose–response study. Int J Obstet Anesth 2012; 21: 222-9.CrossRefPubMed

12.

Ezz G, Fathi HM, Abd Eldayem HM. Effect of intrathecal dexmedetomidine on the quality of combined spinal epidural analgesia and obstetric outcome during vaginal delivery. Res Opin Anesth Intensive Care 2017; 4: 23-8.CrossRef

13.

Li C, Wu Y, Fan J. Effect of two different times for intravenous dexmedetomidine alleviates shivering during parturients cesarean delivery under combined spinal-epidural anaesthesia. J Clin Anesthesiol 2017; 33: 868-71.

14.

Crossley AW, Mahajan RP. The intensity of postoperative shivering is unrelated to axillary temperature. Anaesthesia 1994; 49: 205-7.CrossRefPubMed

15.

Filos KS, Goudas LC, Patroni O, Polyzou V. Hemodynamic and analgesic profile after intrathecal clonidine in humans. A dose-response study. Anaesthesia 1994; 81: 591-601; discussion 27A-8A.

16.

Mittal G, Gupta K, Katyal S, Kaushal S. Randomised double-blind comparative study of dexmedetomidine and tramadol for post-spinal anaesthesia shivering. Indian J Anaesth 2014; 58: 257-62.CrossRefPubMedPubMedCentral

17.

Powell RM, Buggy DJ. Ondansetron given before induction of anesthesia reduces shivering after general anesthesia. Anesth Analg 2000; 90: 1423-7.CrossRefPubMed

18.

Kurz A, Sessler DI, Schroeder M, Kurz M. Thermoregulatory response thresholds during spinal anesthesia. Anesth Analg 1993; 77: 721-6.PubMed

19.

Cobb B, Cho Y, Hilton G, Ting V, Carvalho B. Active warming utilizing combined iv fluid and forced-air warming decreases hypothermia and improves maternal comfort during cesarean delivery: a randomized control trial. Anesth Analg 2016; 122: 1490-7.CrossRefPubMed

20.

Saito T, Sessler DI, Fujita K, Ooi Y, Jeffrey R. Thermoregulatory effects of spinal and epidural anesthesia during cesarean delivery. Reg Anesth Pain Med 1998; 23: 418-23.PubMed

21.

Butwick AJ, Lipman SS, Carvalho B. Intraoperative forced air-warming during cesarean delivery under spinal anesthesia does not prevent maternal hypothermia. Anesth Analg 2007; 105: 1413-9.CrossRefPubMed

22.

Bajwa SJ, Gupta S, Kaur J, Singh A, Parmar S. Reduction in the incidence of shivering with perioperative dexmedetomidine: a randomized prospective study. J Anaesthesiol Clin Pharmacol 2012; 28: 86-91.CrossRefPubMedPubMedCentral

23.

Elvan EG, Öç B, Uzun Ş, Karabulut E, Coşkun F, Aypar Ü. Dexmedetomidine and postoperative shivering in patients undergoing elective abdominal hysterectomy. Eur J Anaesthesiol 2008; 25: 357-64.CrossRef

24.

Easley RB, Brady KM, Tobias JD. Dexmedetomidine for the treatment of postanesthesia shivering in children. Pediatr Anesth 2007; 17: 341-6.CrossRef

25.

Liu ZX, Xu FY, Liang X, et al. Efficacy of dexmedetomidine on postoperative shivering: a meta-analysis of clinical trials. Can J Anesth 2015; 62: 816-29.CrossRefPubMed

26.

Nasseri K, Ghadami N, Nouri B. Effects of intrathecal dexmedetomidine on shivering after spinal anesthesia for cesarean section: a double-blind randomized clinical trial. Drug Des Devel Ther 2017; 11: 1107-13.CrossRefPubMedPubMedCentral

27.

He L, Xu JM, Liu SM, Chen ZJ, Li X, Zhu R. Intrathecal dexmedetomidine alleviates shivering during cesarean delivery under spinal anesthesia. Biol Pharm Bull 2017; 40: 169-73.CrossRefPubMed

28.

Usta B, Gozdemir M, Demircioglu RI, Muslu B, Sert H, Yaldiz A. Dexmedetomidine for the prevention of shivering during spinal anesthesia. Clinics (Sao Paulo) 2011; 66: 1187-91.CrossRef

29.

Talke P, Tayefeh F, Sessler DI, Jeffrey R, Noursalehi M, Richardson C. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology 1997; 87: 835-41.CrossRefPubMed

30.

Piao G, Wu J. Systematic assessment of dexmedetomidine as an anesthetic agent: a meta-analysis of randomized controlled trials. Arch Med Sci 2014; 10: 19-24.CrossRefPubMedPubMedCentral

31.

Kundra TS, Kaur P. The minimum dose of dexmedetomidine required for cessation of postspinal anesthesia shivering: a prospective observational study. J Anaesthesiol Clin Pharmacol 2017; 33: 493-5.CrossRefPubMedPubMedCentral

32.

Abdel-Ghaffar HS, Mohamed SA, Fares KM, Osman MA. Safety and efficacy of dexmedetomidine in treating post spinal anesthesia shivering: a randomized clinically controlled dose-finding trial. Pain Physician 2016; 19: 243-53.PubMed

33.

Yoshimura M, Kunisawa T, Suno M, et al. Intravenous dexmedetomidine for cesarean delivery and its concentration in colostrum. Int J Obstet Anesth 2017; 32: 28-32.CrossRefPubMed

Titel: Intravenous dexmedetomidine for the treatment of shivering during Cesarean delivery under neuraxial anesthesia: a randomized-controlled trial
verfasst von: Christina Lamontagne, MD, FRCP
Sandra Lesage, MD, FRCP
Edith Villeneuve, MD, FRCP
Elsa Lidzborski, MD
Alex Derstenfeld, BASc, BCL, LLB
Chantal Crochetière, MD, FRCP
Publikationsdatum: 03.04.2019
Verlag: Springer International Publishing
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 7/2019
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI: https://doi.org/10.1007/s12630-019-01354-3

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Intravenous dexmedetomidine for the treatment of shivering during Cesarean delivery under neuraxial anesthesia: a randomized-controlled trial